Latest Breaking News On - கிளைவ் ஸ்வேண்ட்செங் - Page 1 : comparemela.com

Cedars-Sinai receives $11.99 million from CIRM to launch ALS clinical trial Cedars-Sinai has been awarded $11.99 million by California s stem cell agency to launch a clinical trial testing a potential gene and stem cell therapy for amyotrophic lateral sclerosis (ALS). ALS, or Lou Gehrig s disease, is a progressive neurodegenerative disease that damages nerve cells known as motor neurons in the brain and spinal cord that control voluntary muscle movement. It affects an estimated 16,000 people in the U.S. and is usually fatal within five years of diagnosis. There is no known cure and only limited treatments that may slow progression in a subset of patients.

United statesClive svendsenLou gehrigRichard lewisPablo avalosAdam mamelakEmily hendersonCalifornia institute for regenerative medicineSinai biomanufacturing centerRegenerative medicine instituteAllen research institute at cedarsProfessor of biomedical sciencesSinai board of governors regenerative medicine instituteCalifornia instituteRegenerative medicineExecutive director